Key Takeaways:
- Aegon sells its UK division to Standard Life in a £2.0 billion deal.
- Consideration is 15.3% of Standard Life stock and £0.75 billion in cash.
- Aegon pivots to US market, plans deleveraging and share buybacks.
Back
Back
Aegon sells UK arm to Standard Life for £2.0 billion
Aegon will sell its UK-based business to Standard Life for £2.0 billion, a decisive move that completes its strategic review and accelerates its pivot to becoming a leading US life insurance and retirement group. The transaction was announced on April 15, 2026.
"This transaction marks the completion of the strategic review of Aegon UK, further supporting Aegon in its ambition to become a leading US life insurance and retirement group," the company said in a statement.
The £2.0 billion consideration consists of a 15.3% shareholding in Standard Life, valued at 181.1 million shares, and a cash payment of £0.75 billion. The total price is equivalent to 14.2 times Aegon UK's 2025 operating result after tax and 1.9 times its IFRS Shareholder's equity.
The deal reshapes the UK insurance landscape while allowing Aegon to redeploy capital to the US. Aegon plans to use the cash proceeds for a mix of deleveraging and share buybacks after the transaction closes, which is expected around the end of 2026, subject to regulatory approvals.
As part of the agreement, Aegon is entitled to appoint one non-Executive Director to the Board of Standard Life. Aegon's asset management activities in the UK will remain part of its global asset manager and will serve as a key partner for the newly combined entity. The company will update its 2026 and 2027 financial ambitions to reflect the sale, maintaining its growth targets from an adjusted base.
This article is for informational purposes only and does not constitute investment advice.
Features
Resources
© 2026 Finture Development Limited. All rights reserved